Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Tumor antigen-targeted IL-15 complex eliminates lymphoma cells

Nov. 18, 2014

Japanese researchers describes anti-NLRR-1 MAbs

Nov. 14, 2014

Advaxis submits IND for phase I/II study of ADXS-HPV and MEDI-4736 for HPV-related cancers

Nov. 14, 2014

Glionova Therapeutics raises financing for clinical development of glioblastoma candidate

Nov. 14, 2014

Novel anti-PD-L1 therapy shows promise in in vitro and in vivo bladder tumor models

Nov. 13, 2014

Oncothyreon and Celldex start phase I trial of MUC1 vaccine and anti-CD27 antibody combination

Nov. 11, 2014

AVEO Pharma designs anti-Notch 1 MAbs

Nov. 11, 2014

Kancera selects first candidate in ROR project

Nov. 5, 2014

Altor BioScience begins development of ALT-803 for multiple myeloma

Nov. 5, 2014

arGEN-X files IND to begin study of ARGX-110 in Waldenstrom's macroglobulinemia

Nov. 4, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...